483
Milind Javle, MDMilind Javle, MD – FDA 483, Dec 21, 2020
Record Details
Milind Javle, MD, a clinical investigator in Houston, TX, was cited for significant deficiencies during an FDA inspection. Observations included lapses in IRB continuing review, failure to adhere to the investigational plan for subject procedures, and critical failures in obtaining informed consent and timely reporting of serious adverse events to the sponsor. These issues indicate a lack of control over key aspects of clinical trial conduct and subject protection.
View Company Profile
ID · d0ecb325-9063-412f-b063-de60126d9eab
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.